Wells Fargo & Company MN trimmed its holdings in shares of athenahealth, Inc. (NASDAQ:ATHN) by 1.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 82,048 shares of the health services provider’s stock after selling 1,631 shares during the period. Wells Fargo & Company MN owned 0.21% of athenahealth worth $11,532,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in ATHN. Swiss National Bank increased its holdings in shares of athenahealth by 1.1% in the 2nd quarter. Swiss National Bank now owns 65,830 shares of the health services provider’s stock valued at $9,252,000 after acquiring an additional 700 shares during the period. Wesbanco Bank Inc. boosted its stake in athenahealth by 96.7% during the 2nd quarter. Wesbanco Bank Inc. now owns 12,461 shares of the health services provider’s stock worth $1,751,000 after purchasing an additional 6,125 shares during the period. Scout Investments Inc. boosted its stake in athenahealth by 67.2% during the 2nd quarter. Scout Investments Inc. now owns 115,663 shares of the health services provider’s stock worth $16,256,000 after purchasing an additional 46,507 shares during the period. Keybank National Association OH boosted its stake in athenahealth by 80.1% during the 2nd quarter. Keybank National Association OH now owns 6,412 shares of the health services provider’s stock worth $901,000 after purchasing an additional 2,851 shares during the period. Finally, Allen Investment Management LLC boosted its stake in athenahealth by 66.5% during the 2nd quarter. Allen Investment Management LLC now owns 6,133 shares of the health services provider’s stock worth $862,000 after purchasing an additional 2,449 shares during the period.

In other news, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $130.38, for a total transaction of $39,114.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $140.95, for a total transaction of $112,760.00. The disclosure for this sale can be found here. Insiders sold 10,922 shares of company stock valued at $1,546,993 over the last quarter. Corporate insiders own 3.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.thecerbatgem.com/2017/10/03/athenahealth-inc-athn-holdings-cut-by-wells-fargo-company-mn.html.

A number of research analysts have commented on the stock. ValuEngine upgraded shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Evercore ISI restated an “outperform” rating and issued a $163.00 price target (up previously from $155.00) on shares of athenahealth in a research report on Saturday, July 22nd. Cowen and Company cut athenahealth from an “outperform” rating to a “market perform” rating and boosted their price target for the company from $127.00 to $133.00 in a research report on Monday, July 31st. Jefferies Group LLC reaffirmed a “hold” rating and set a $135.00 price objective on shares of athenahealth in a research note on Monday, June 26th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $151.00 price objective (up from $106.00) on shares of athenahealth in a research report on Friday, June 16th. Three investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and twelve have given a buy rating to the stock. athenahealth presently has a consensus rating of “Hold” and an average target price of $149.91.

Shares of athenahealth, Inc. (NASDAQ ATHN) opened at 125.40 on Tuesday. The company’s 50-day moving average is $133.33 and its 200-day moving average is $129.69. The stock has a market capitalization of $5.01 billion, a PE ratio of 159.14 and a beta of 1.76. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. The firm had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The firm’s revenue was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.34 earnings per share. Equities research analysts expect that athenahealth, Inc. will post $1.91 earnings per share for the current fiscal year.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.